Scholar Rock Holding (SRRK) Research & Development (2017 - 2026)
Scholar Rock Holding (SRRK) recorded Research & Development of $58.23 million in Q2 2026, down 6.7% from $62.4 million a year earlier but up 12.4% from the prior quarter.
Powered by 
Analysis
Scholar Rock Holding (SRRK) Research & Development (2017 - 2026) Analysis & Trends
On a TTM basis, Scholar Rock Holding's Research & Development came in at $207.41 million as of Jun 30, 2026, down 1.3% year-over-year; for FY2025, it was $208.44 million, up 12.9% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 23.0% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $184.55 million in FY2024 (+51.4%), $121.9 million in FY2023 (-2.0%), $124.44 million in FY2022 (+14.7%) and $108.47 million in FY2021 (+46.5%).
- Quarterly Research & Development has ranged from $26.87 million in Q2 2023 to $62.4 million in Q2 2025 over the past five years.
- On a year-over-year basis, Research & Development rose in six of the last eight quarters, with growth averaging 20.2%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 70.1% in Q3 2021, against a decline of 16.2% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $51.81 million (Q1 2026), $46.88 million (Q4 2025) and $50.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Scholar Rock Holding | 5.97 Bn | 5.97 Bn | - | 58.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.23 Mn |
| Mar 31, 2026 | 51.81 Mn |
| Dec 31, 2025 | 46.88 Mn |
| Sep 30, 2025 | 50.49 Mn |
| Jun 30, 2025 | 62.40 Mn |
| Mar 31, 2025 | 48.68 Mn |
| Dec 31, 2024 | 50.37 Mn |
| Sep 30, 2024 | 48.72 Mn |
| Jun 30, 2024 | 42.37 Mn |
| Mar 31, 2024 | 43.09 Mn |
| Dec 31, 2023 | 34.96 Mn |
| Sep 30, 2023 | 30.34 Mn |
| Jun 30, 2023 | 26.87 Mn |
| Mar 31, 2023 | 29.74 Mn |
| Dec 31, 2022 | 29.61 Mn |
| Sep 30, 2022 | 33.39 Mn |
| Jun 30, 2022 | 32.07 Mn |
| Mar 31, 2022 | 29.37 Mn |
| Dec 31, 2021 | 29.05 Mn |
| Sep 30, 2021 | 31.27 Mn |
API Access
Scholar Rock Holding Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SRRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SRRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SRRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();